Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.5% beneficial ownership stake in Avis Budget Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.7% of Liberty Broadband Corp's Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.5% beneficial ownership stake in Viking Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its significant passive ownership stake of 15.4% in ACI Worldwide, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.4% Stake in Alpha Metallurgical Resources
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 12.4% of Alpha Metallurgical Resources, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.5% Stake in Synaptics Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 12.5% of Synaptics Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 15.1% Stake in Yelp Inc.
BlackRock, Inc. has filed an updated Schedule 13G, disclosing a continued beneficial ownership of 15.1% of Yelp Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 11.5% Passive Stake in Insperity, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 11.5% in Insperity, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 12.7% of Corcept Therapeutics Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.7% beneficial ownership stake in Rogers Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.8% Stake in Enova International, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.8% beneficial ownership stake in Enova International, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.2% beneficial ownership stake in Foreign Trade Bank of Latin America, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 10.5% beneficial ownership stake in Ovintiv Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 12.4% beneficial ownership stake in iShares Trust as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.3% beneficial ownership stake in iShares Trust as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Files Amended Schedule 13G for iShares Trust, Disclosing Passive Ownership and Subsidiary Holdings
BlackRock, Inc. has filed an amended Schedule 13G with the SEC, reporting a 0.0% beneficial ownership stake in iShares Trust's Common Stock for its aggregated reporting units as of March 31, 2025, while identifying a subsidiary with a greater than 5% holding.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 3.9% beneficial ownership stake in iShares, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 2.1% Passive Stake in iShares Trust
BlackRock, Inc. has filed an amended Schedule 13G, confirming its passive beneficial ownership of 2.1% of iShares Trust's Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 3.8% beneficial ownership stake in iShares, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 3.7% Stake in iShares Trust Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 3.7% in iShares Trust Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 1.4% Passive Stake in BlackRock ETF Trust II
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.4% beneficial ownership stake in BlackRock ETF Trust II as of March 31, 2025, held for investment purposes.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 4.4% passive beneficial ownership stake in Elanco Animal Health Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in National Research Corp, Holding 4.4% of Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a continued passive beneficial ownership of 4.4% in National Research Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.7% in Unity Bancorp Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.0% passive beneficial ownership stake in Columbia Sportswear Co. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.6% Stake in CAE Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 4.6% of CAE Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.7% beneficial ownership stake in Comstock Resources Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Reduces Stake in Provident Bancorp to Below 5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of Provident Bancorp, Inc. common stock to 4.9% as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 4.8% Passive Stake in Larimar Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.8% of Larimar Therapeutics, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.8% beneficial ownership stake in B. Riley Financial, Inc. as of March 31, 2025.